The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
SH now being asked where SNG001 should be administered. Mentioning long covid, how SNG001 may alleviate, awaiting HT results, "a portfolio moving towards preventative measures" not just treatment.
Sir Stephen has just given a summary of SNG001 trials, mentioned USA, nothing we didn't know. Someone just asked him why it wasn't included in the Recovery trials ... I thought this had been discussed to death. We are oast that stage.. Oooh - now being asked about home trial. He is describing the HT process.
My sincere apologies - I don't know why treatments weren't covered today. Their summary was dated 19 hours ago and there was no Sunday broadcast. Today's broadcast was about vaccines and breast cancer. I'm still looking.
Today's briefing includes OUTPATIENT TREATMENTS and should cover SNG001. Their summary says:
"Mario Castro, MD, pulmonologist and researcher, recently joined our Morning Media Update this morning to talk about new clinical trials testing three new outpatient treatments that may be game changers for COVID patients. To volunteer for these trials, potential participants must be within 10 days of the onset of symptoms and within seven days of a positive test. Contact the study coordinator, Luigi Boccardi, at 913-588-4022. To learn more."
The update broadcsats from: https://www.kansashealthsystem.com/patient-visitor/covid19-update/covid19-newsroom at 08.00 local time which is 14.00 GMT.
Doc: "Infrastructure for rolling it out as an At Home treatment will take months more to set up."
I wonder if it won't be much faster. The way Kansas and other states are enthusiastically setting up their ACTIV-2 trials will be giving them first hand experience in delivering, monitoring and supporting SNG001 in home settings. I would expect the US will be handing this on a 'state basis', not federal. If they have enough kits then it will all be down to scaling their support staff.
Happy - go and read all of the extensive evidence on the Synairgen Reddit page, watch all the videos, research the results of the trials to date and look into the data compiled from Synairgen's founders' 15 years' research into the action of interferon beta.
Only then can you come on here and put your point of view and expect to be taken seriously.
This is the NIH page which lists all drugs being trialled, from ACTIV-1 to ACTIV-5. Follows on from the earlier NIH update.
https://www.nih.gov/research-training/medical-research-initiatives/activ/covid-19-therapeutics-prioritized-testing-clinical-trials
The NIH News page has posted this update today, now listing SNG001 as being on ACTIV-2.
And ... SNG001 is the FIRST treatment to have been administered!
Quote from their release "The first volunteer enrolled in the SNG001 sub-study on February 10. The other agents under study are expected to begin enrolling participants soon."
Here's the page: https://www.nih.gov/news-events/news-releases/four-potential-covid-19-therapeutics-enter-phase-2-3-testing-nih-activ-2-trial
Finally ... here is the correct Kansas Daily Update video page: https://www.facebook.com/kuhospital/videos/225051529263564
Sorry, my error. I think the Kansas Daily Update page can be found here:
https://www.kansashealthsystem.com/patient-visitor/covid19-update/covid19-newsroom
I think Kansas City is GMT-6 (they are on Central Standard Time), so that makes it a 2pm GMT start.
Their FB page for the update stream is: https://www.facebook.com/kuhospital/photos/a.10150374112643104/10159107699333104/
This afternoon at 4pm GMT. I know, vaccines and more vaccines but it's always worthwhile to monitor it ... one day soon.
https://www.whitehouse.gov/live/